Corcept Therapeutics
CORT
#2078
Rank
C$12.53 B
Marketcap
C$118.95
Share price
1.71%
Change (1 day)
42.77%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : C$8.78 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is C$8.78 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$9.95 M4869.58%
2023-12-31C$0.2 M-87.09%
2022-12-31C$1.55 M131.37%
2021-12-31C$0.67 M-79.39%
2020-12-31C$3.25 M-28.04%
2019-12-31C$4.52 M
2018-12-31N/A
2016-12-31C$19.7 M-5.07%
2015-12-31C$20.75 M89.82%
2014-12-31C$10.93 M78.89%
2013-12-31C$6.11 M131.99%
2012-12-31C$2.63 M
2010-12-31N/A-100%
2009-12-31C$0 M-67.55%
2008-12-31C$0.01 M-32.75%
2007-12-31C$0.02 M-40.84%
2006-12-31C$0.04 M-22.22%
2005-12-31C$0.06 M
2003-12-31C$0.67 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$63.26 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$70.51 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$44.23 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$58.72 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$84.06 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$57.15 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.42 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$0.16 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.83 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA